Popular topics
Health technology, digital therapeutics, biotech, and the slow remaking of medical practice through software and devices.
702 articles · Health Tech & Medtech
The future of liver disease treatment may arrive not on a surgical table, but through a syringe.
A study published in Nature Communications found that a 50 per cent chance of pain is more stressful than pain itself — which reframes premature decisions as a coping mechanism, not a personality trait.
Cell reprogramming — the technique of returning adult cells to a more youthful state using four genetic factors identified in Nobel Prize-winning research — has become the buzziest approach in longevity science, displacing earlier obsessions with telomere lengthening and senolytic drugs.
In July 1969, Apollo 11's crew was sealed in an Airstream trailer for 21 days while NASA tested moon rocks for life that wasn't there — meanwhile, the ocean beneath their splashdown site held vampire squid, 40-meter siphonophores, and single-celled organisms the size of dinner plates.
Amsterdam’s Healthplus.ai has raised €2.3M to develop further and expand its AI technology, designed to support hospitals in managing surgical care.
Dutch AI company Guideways, helping medtech businesses navigate regulatory and compliance, has raised pre-seed financing.
AstraZeneca finalises buyout of SixPeaks Bio to accelerate advanced obesity treatment pipeline.
YON E Health raises €250K to develop tech that supports early detection and data-driven insights in women’s reproductive and vaginal health.
Warsaw-based Holi has completed a new funding round to grow its operations and expand its digital health services in Europe.
ONWARD Medical raises funding in an accelerated bookbuild backed by Ottobock, Invus, and ASR Global Impact Fund to advance its breakthrough neurotechnology therapies.
Barcelona-based VC fund manager Inverady has backed a homegrown biotech firm in a new funding round, along with existing investors.
Dublin-based Deciphex, a company specialised in AI-powered digital pathology, has secured €15M from Claret Capital Partners.
